We are live on ! Find out more
MRM

MEDIROM Healthcare Technologies

4 hedge funds and large institutions have $1.13M invested in MEDIROM Healthcare Technologies in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 24 (+2)

11% more capital invested

Capital invested by funds: $1.02M → $1.13M (+$113K)

0.58% more ownership

Funds ownership: 1.47%2.05% (+0.58%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$7.15K
Name Holding Trade Value Shares
Change
Change in
Stake
MS
1
Mizuho Securities
Japan
$782K
Citadel Advisors
2
Citadel Advisors
Florida
$218K +$248K +19,626 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$113K +$129K +10,174 New
UBS Group
4
UBS Group
Switzerland
$21K -$7.15K -566 -24%

MRM Hedge Fund Activity: Q1 2021 in Review

4 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q1 2021, worth a combined $1.13M — up 11% from $1.02M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MRM positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $248K. The largest seller was UBS Group, cutting an estimated $7.15K.

  • 4 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q1 2021, up from 2 in Q4 2020.
  • Funds reported $1.13M of MEDIROM Healthcare Technologies stock for Q1 2021, up 11% quarter-over-quarter.
  • 2 funds opened new MEDIROM Healthcare Technologies positions in Q1 2021 and 0 closed out, a net change of +2 holders.
  • The largest MEDIROM Healthcare Technologies buyer in Q1 2021 was Citadel Advisors, an estimated $248K added.
  • The largest MEDIROM Healthcare Technologies seller in Q1 2021 was UBS Group, an estimated $7.15K sold.

Based on aggregated 13F filings for Q1 2021.